204 related articles for article (PubMed ID: 20534090)
21. Localized mucosal leishmaniasis due to Leishmania (Leishmania) infantum: clinical and microbiologic findings in 31 patients.
Aliaga L; Cobo F; Mediavilla JD; Bravo J; Osuna A; Amador JM; Martín-Sánchez J; Cordero E; Navarro JM
Medicine (Baltimore); 2003 May; 82(3):147-58. PubMed ID: 12792301
[TBL] [Abstract][Full Text] [Related]
22. Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe.
Rihl M; Stoll M; Ulbricht K; Bange FC; Schmidt RE
J Infect; 2006 Jul; 53(1):e25-7. PubMed ID: 16274744
[TBL] [Abstract][Full Text] [Related]
23. Holiday souvenirs from the Mediterranean: three instructive cases of visceral leishmaniasis.
Buonomano R; Brinkmann F; Leupin N; Boscacci R; Zimmermann A; Müller N; Fux CA
Scand J Infect Dis; 2009; 41(10):777-81. PubMed ID: 19593691
[TBL] [Abstract][Full Text] [Related]
24. [Mucosal localization of leishmaniasis in Tunisia: 5 cases].
Kharfi M; Fazaa B; Chaker E; Kamoun MR
Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):27-30. PubMed ID: 12605153
[TBL] [Abstract][Full Text] [Related]
25. Antimony-resistant Leishmania donovaniin eastern Sudan: incidence and in vitro correlation.
Abdo MG; Elamin WM; Khalil EA; Mukhtar MM
East Mediterr Health J; 2003 Jul; 9(4):837-43. PubMed ID: 15748080
[TBL] [Abstract][Full Text] [Related]
26. Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil.
Amato VS; Tuon FF; Imamura R; Abegão de Camargo R; Duarte MI; Neto VA
J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1026-34. PubMed ID: 19453817
[TBL] [Abstract][Full Text] [Related]
27. Localized cutaneous leishmaniasis due to Leishmania donovani and Leishmania tropica: preliminary findings of the study of 161 new cases from a new endemic focus in himachal pradesh, India.
Sharma NL; Mahajan VK; Kanga A; Sood A; Katoch VM; Mauricio I; Singh CD; Parwan UC; Sharma VK; Sharma RC
Am J Trop Med Hyg; 2005 Jun; 72(6):819-24. PubMed ID: 15964970
[TBL] [Abstract][Full Text] [Related]
28. Case Report: A Single-Center Case Series on Skin Manifestations of Leishmaniasis from a Non-Endemic State in Southern India.
Tharakan SJ; Peter Cv D; Karthik R; Rupa V; Rose W; Thomas M; Manuel M; Rupali P; Pulimood S; Rao Ajjampur SS
Am J Trop Med Hyg; 2020 Dec; 104(3):928-933. PubMed ID: 33377447
[TBL] [Abstract][Full Text] [Related]
29. Post-kala-azar dermal leishmaniasis (PKDL): the first case report from Nepal.
Karki P; Koirala S; Parija SC; Sethi M; Das ML
Southeast Asian J Trop Med Public Health; 2003 Mar; 34(1):22-3. PubMed ID: 12971510
[TBL] [Abstract][Full Text] [Related]
30. First report of mucosal tissue localisation of leishmaniasis in Sri Lanka.
Rajapaksa US; Ihalamulla RL; Karunaweera ND
Ceylon Med J; 2005 Jun; 50(2):90-1. PubMed ID: 16114778
[No Abstract] [Full Text] [Related]
31. [Recidivant laryngeal leishmaniasis: an unusual case in an immunocompetent patient treated with corticosteroids].
Casero R; Laconte L; Fraenza L; Iglesias N; Quinteros Greco C; Villablanca M
Rev Argent Microbiol; 2010; 42(2):118-21. PubMed ID: 20589333
[TBL] [Abstract][Full Text] [Related]
32. A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasis.
Llanos-Cuentas A; Calderón W; Cruz M; Ashman JA; Alves FP; Coler RN; Bogatzki LY; Bertholet S; Laughlin EM; Kahn SJ; Beckmann AM; Cowgill KD; Reed SG; Piazza FM
Vaccine; 2010 Oct; 28(46):7427-35. PubMed ID: 20851080
[TBL] [Abstract][Full Text] [Related]
33. Sudanese mucosal leishmaniasis: isolation of a parasite within the Leishmania donovani complex that differs genotypically from L. donovani causing classical visceral leishmaniasis.
Mahdi M; Elamin EM; Melville SE; Musa AM; Blackwell JM; Mukhtar MM; Elhassan AM; Ibrahim ME
Infect Genet Evol; 2005 Jan; 5(1):29-33. PubMed ID: 15567136
[TBL] [Abstract][Full Text] [Related]
34. Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate.
Solomon M; Baum S; Barzilai A; Pavlotsky F; Trau H; Schwartz E
J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1189-92. PubMed ID: 19298486
[TBL] [Abstract][Full Text] [Related]
35. Hypersensitivity reaction over lesions of post-kala-azar dermal leishmaniasis mimicking type 1 reaction in leprosy.
Dhar S; Malakar S
Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):66-7. PubMed ID: 10407631
[No Abstract] [Full Text] [Related]
36. Ketoconazole in antimonial unresponsive cases of Kala-azar.
Jha TK; Singh NK; Jha S
J Assoc Physicians India; 1995 May; 43(5):347. PubMed ID: 9081966
[No Abstract] [Full Text] [Related]
37. Leishmania donovani: an in vitro study of antimony-resistant amphotericin B-sensitive isolates.
Sharief AH; Gasim Khalil EA; Theander TG; Kharazmi A; Omer SA; Ibrahim ME
Exp Parasitol; 2006 Dec; 114(4):247-52. PubMed ID: 16716301
[TBL] [Abstract][Full Text] [Related]
38. Emergence of visceral leishmaniasis in Sri Lanka: a newly established health threat.
Siriwardana HVYD; Karunanayake P; Goonerathne L; Karunaweera ND
Pathog Glob Health; 2017 Sep; 111(6):317-326. PubMed ID: 28820339
[TBL] [Abstract][Full Text] [Related]
39. Detection of Leishmania infantum kinetoplast DNA in laryngeal tissue from an immunocompetent patient.
Guddo F; Gallo E; Cillari E; La Rocca AM; Moceo P; Leslie K; Colby T; Rizzo AG
Hum Pathol; 2005 Oct; 36(10):1140-2. PubMed ID: 16226116
[TBL] [Abstract][Full Text] [Related]
40. Differential interferon- gamma production characterizes the cytokine responses to Leishmania and Mycobacterium leprae antigens in concomitant mucocutaneous leishmaniasis and lepromatous leprosy.
Matos DS; Azeredo-Coutinho RB; Schubach A; Conceição-Silva F; Baptista C; Moreira JS; Mendonça SC
Clin Infect Dis; 2005 Jan; 40(2):e5-12. PubMed ID: 15655736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
